All In MedTech

Device Trial Radar · NCT07124390

Electroacupuncture as a Treatment for Refractory Overactive Bladder

Electroacupuncture as a Treatment for Refractory Overactive Bladder: A Feasibility /Pilot Randomized Controlled Trial

Last checked: Nov 19, 2026Latest source record: Aug 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

24

Planned (sponsor's estimate)

Start

Aug 15, 2026

Primary completion

Nov 30, 2027

Study completion Dec 30, 2027

Sponsor

Lead sponsor
Chelsea and Westminster NHS Foundation TrustAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Imperial College London
First posted
Aug 15, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a single-site feasibility randomised controlled trial evaluating the feasibility and acceptability of electroacupuncture (EA), and percutaneous tibial nerve stimulation (PTNS), in women with refractory overactive bladder (OAB) who have not achieved satisfactory improvement following standard pelvic health physiotherapy. The primary aim is to determine whether a larger definitive trial is feasible by assessing recruitment, consent, retention, treatment adherence, data completeness, intervention delivery, safety, and participant acceptability. Twenty-four participants will be randomly allocated to receive electroacupuncture or PTNS, over a 12-week treatment period. Outcome assessments will be completed at baseline, 6 weeks, 12 weeks, 6 months, and 12 months. The findings will inform the design of a future definitive randomised controlled trial and contribute to the evidence base for non-pharmacological treatment options for overactive bladder.

Conditions

  • Over Active Bladder
  • Urinary Incontinence (UI)
  • Nocturia

Interventions

  • Name: Electroacupuncture (EA) Type: Device-based acupuncture therapyDevice

    Description: Insertion of acupuncture needles at specific points with electrical stimulation (20 Hz) for 30 minutes per session.

  • Neuromodulation therapyDevice

    Type: Neuromodulation therapy Description: Insertion of a needle electrode near the medial malleolus with low-voltage electrical stimulation (20 Hz) applied for 30 minutes per session.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Frequency and Severity of Adverse EventsTime frame: Baseline, during each treatment session, 6 weeks, 12 weeks, and throughout study participation up to 12 weeks after randomisation.
  2. Recruitment RateTime frame: At completion of recruitment (anticipated recruitment period: Sept 2026 to March 2027.
  3. Participant Retention and Follow-up Completion Rate.Time frame: 6 weeks, 12 weeks, 6 months, and 12 months after randomisation.

2 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Chelsea and Westminster hospital NHS foundation Trust

    London, United Kingdom, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.